Andrade Hiury S, Zargar Homayoun, Akca Oktay, Caputo Peter A, Ramirez Daniel, Kara Onder, Stein Robert J, Chueh Shih-Chieh J, Kaouk Jihad H
Glickman Urological and Kidney Institute , Cleveland Clinic, Cleveland, Ohio.
J Endourol. 2016 Apr;30(4):379-83. doi: 10.1089/end.2015.0510. Epub 2016 Feb 5.
To analyze the outcomes of robotic partial nephrectomy (RPN) in patients where nephron-sparing surgery would have mandated a large amount of renal volume resection.
Patients undergoing RPN with extensive volume resection (≥30%), from 2006 to 2014, were identified. Pre- and postoperative CT/MRI-based volumetric assessment of the operated kidney was performed. To address the possible benefits of RPN, we matched this cohort to patients undergoing laparoscopic radical nephrectomy (LRN). The groups were matched for tumor size, R.E.N.A.L. nephrometry score, age-adjusted Charlson comorbidity index (ACCI), and preoperative estimated glomerular filtration rate (eGFR). Demographics, perioperative, functional, and oncologic outcomes were compared between the groups. Multivariable analysis of factors predicting chronic kidney disease (CKD) upstaging (type of surgery, R.E.N.A.L. score, ACCI, and baseline eGFR) was performed.
In total, 52 patients undergoing RPN were matched to 52 LRN patients. The median R.E.N.A.L. score (interquartile range) was 9 (9-10) for both groups. Demographic variables were comparable between the groups. The median renal volume preservation in the RPN group was 57.0% (47.2-67.2). The rates of overall and major complications were comparable between RPN and LRN. The RPN group had higher overall eGFR preservation (75.8% vs 68.5%; p = 0.01) and a lower rate of CKD upstaging (26.9% vs 50.6%; p = 0.001). On multivariable analysis, LRN and baseline eGFR were significant predictors of CKD upstaging (odds ratio [OR] 4.26; 95% CI [1.80-10.12]; p = 0.001 and OR 0.98; 95% CI [0.96-0.99]; p = 0.03, respectively). During the median follow-up time of 21 (9-36) months, local recurrence, metastasis, and cancer-specific and overall survival were comparable between RPN and LRN.
RPN requiring extensive volume resection provides renal functional preservation without significant increase in surgical complications or compromising short-term oncologic outcomes.
分析在需要进行大量肾实质切除的肾单位保留手术患者中,机器人辅助部分肾切除术(RPN)的治疗效果。
确定2006年至2014年期间接受广泛肾实质切除(≥30%)的RPN患者。基于术前和术后CT/MRI对手术肾脏进行体积评估。为探讨RPN的潜在益处,将该队列与接受腹腔镜根治性肾切除术(LRN)的患者进行匹配。两组在肿瘤大小、R.E.N.A.L.肾计量评分、年龄校正的Charlson合并症指数(ACCI)和术前估计肾小球滤过率(eGFR)方面进行匹配。比较两组的人口统计学、围手术期、功能和肿瘤学结果。对预测慢性肾脏病(CKD)分期进展的因素(手术类型、R.E.N.A.L.评分、ACCI和基线eGFR)进行多变量分析。
总共52例接受RPN的患者与52例LRN患者进行匹配。两组的R.E.N.A.L.评分中位数(四分位间距)均为9(9-10)。两组的人口统计学变量具有可比性。RPN组的肾实质保留中位数为57.0%(47.2-67.2)。RPN组和LRN组的总体并发症和主要并发症发生率相当。RPN组的总体eGFR保留率更高(75.8%对68.5%;p = 0.01),CKD分期进展率更低(26.9%对50.6%;p = 0.001)。在多变量分析中,LRN和基线eGFR是CKD分期进展的显著预测因素(优势比[OR] 4.26;95%置信区间[1.80-10.12];p = 0.001和OR 0.98;95%置信区间[0.96-0.99];p = 0.03,分别)。在中位随访时间21(9-36)个月期间,RPN组和LRN组的局部复发、转移、癌症特异性生存率和总生存率相当。
需要进行广泛肾实质切除的RPN可保留肾功能,且手术并发症无显著增加,也不影响短期肿瘤学结果。